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Introduction
After endocytosis, proteins and lipids that are destined for lyso-
somal degradation are first incorporated into intraluminal vesi-
cles of multivesicular bodies (MVBs) and are then delivered to 
lysosomes  for  degradation  (Gruenberg  and  Stenmark,  2004; 
Piper and Katzmann, 2007). Alternatively, MVBs can directly 
fuse with the plasma membrane, leading to release of the intra-
luminal vesicles into the extracellular environment as exosomes, 
where they play an important role in processes such as protein 
turnover, intercellular signaling, transfer of mRNA, angiogenesis, 
and tumor spreading (Lakkaraju and Rodriguez-Boulan, 2008; 
Schorey and Bhatnagar, 2008; Buschow et al., 2009; Korkut   
et al., 2009; Simons and Raposo, 2009; Théry et al., 2009).
How proteins and lipids are sorted to these subsets of 
MVBs directed either for lysosomal degradation or for secre-
tion as exosomes is presently unknown. Because the Rab family 
GTPase proteins show a characteristic subcellular distribution 
and represent an important determinant of organelle identity 
(Stenmark, 2009), we address herein the question of cargo sepa-
ration by studying the role of Rab proteins in exosome release 
in oligodendroglial cells.
Although previous work has shown that the subsequent 
activity of Rab5 and -7 is required to transport cargo through 
the endosomal system to lysosomes to mediate its degradation 
(Stenmark, 2009), much less is known about Rabs required for 
delivery of exosomal cargo. To address this issue, we used Oli-neu 
cells, an oligodendroglial cell line that contains a large number 
of MVBs and secretes substantial amounts of exosomes as a 
model system. In these cells, the proteolipid protein (PLP),   
the major protein of myelin of the central nervous system, is   
localized to a large extent in MVBs, from where it can be trans-
ported back to the plasma membrane to be secreted in association 
O
ligodendrocytes secrete vesicles into the extra-
cellular space, where they might play a role in 
neuron–glia communication. These exosomes 
are small vesicles with a diameter of 50–100 nm that are 
formed within multivesicular bodies and are released after 
fusion with the plasma membrane. The intracellular path-
ways that generate exosomes are poorly defined. Because 
Rab family guanosine triphosphatases (GTPases) together 
with their regulators are important membrane trafficking 
organizers, we investigated which Rab GTPase-activating 
proteins interfere with exosome release. We find that 
TBC1D10A–C regulate exosome secretion in a catalytic 
activity–dependent manner. We show that Rab35 is the 
target of TBC1D10A–C and that the inhibition of Rab35 
function leads to intracellular accumulation of endosomal 
vesicles and impairs exosome secretion. Rab35 localizes 
to the surface of oligodendroglia in a GTP-dependent 
manner, where it increases the density of vesicles, sug-
gesting a function in docking or tethering. These findings 
provide a basis for understanding the biogenesis and 
function of exosomes in the central nervous system.
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catalytic domain, the TBC (Tre/Bub2/Cdc16) domain, this   
approach  leads  to  the  selective  inactivation  of  the  different   
Rab proteins (Fuchs et al., 2007; Yoshimura et al., 2007). We 
coexpressed PLP-EGFP with EGFP fusion proteins of all 38 
predicted Rab GAPs, confirmed their expression by Western 
blotting with anti-GFP antibodies in the cell lysates, and deter-
mined the amount of PLP-EGFP in the exosomal membrane 
fraction in three independent experiments. We did not focus on 
the GAPs that seemed to enhance exosome secretion because an 
increase of membrane in the extracellular medium could also be 
caused by more cell debris as a result of cell toxicity. The posi-
tive  candidates  that  reproducibly  reduced  the  release  of   
PLP-GFP with exosomes were reevaluated by comparing the 
effects of the wild-type GAPs with that of the catalytically   
inactive point mutations. We found that TBC1D10B, RN-tre, 
TBC1D10A, TBC1D10C, and TBC1D15 reduced PLP-EGFP 
recovery from the exosomal membrane fraction in a catalytic 
activity–dependent manner (Fig. 1). RN-tre has been reported 
to act on Rab5 (Lanzetti et al., 2000) and Rab43 (Haas et al., 
2005), TBC1D15 on Rab7 (Zhang et al., 2005), TBC1D10A on 
Rab27a (Itoh and Fukuda, 2006), and TBC1D10C on Rab35 
(Patino-Lopez et al., 2008). We reexamined the effects of the 
TBC1D10 family toward specific Rab proteins by testing their 
ability to accelerate GTP hydrolysis in a biochemical assay with 
a wide set of Rabs (Fig. 2). These data clearly show that all 
three members of the TBC1D10 family have strong and Rab35-
specific GAP activity. TBC1D10B, which reduced exosome   
secretion most potently, showed the strongest activity toward 
with exosomes (Trajkovic et al., 2006, 2008; Krämer-Albers   
et al., 2007).
Results and discussion
We started our screen for Rab GTPases in exosome secretion 
by performing a proteome analysis of purified exosomes using 
liquid chromatography (LC) coupled to tandem mass spectrom-
etry (MS; LC-MS/MS). A total of 301 proteins were identified, 
of which approximately one third have been previously found 
in exosomes from other cell types (Barile et al., 2005; Segura   
et al., 2005; Aoki et al., 2007; Valadi et al., 2007; Conde-Vancells 
et al., 2008), confirming the purity of the preparation. Among 
the identified proteins was a relatively large number of Rab   
GTPases (Rab1a, -1b, -2a, -5b, -5c, -6a, -7, -8b, -10, -11b, and 
-35), many of which have previously been implicated in endo-
somal membrane trafficking (Stenmark, 2009). To analyze the 
relative abundance of the Rab GTPases in exosomes, we ex-
pressed all of the identified Rabs as EGFP fusion proteins in 
Oli-neu cells and compared the levels with PLP. As compared 
with PLP-EGFP, Rab proteins were found at relatively low 
levels in exosomes, but among the most abundant was EGFP-
Rab35 (Fig. S1 and Table S1).
To define the requirement of Rab proteins in exosome bio-
genesis, a Rab GTPase-activating protein (GAP) library was 
screened for the ability of each Rab GAP to reduce the secretion 
of PLP-EGFP in association with exosomes. Because Rab 
GAPs promote GTP hydrolysis of Rabs requiring a conserved 
Figure 1.  Screen of a Rab GAP library identifies the TBC1D10 family as regulators of exosome secretion. (A and B) PLP-EGFP was coexpressed with a 
library of 38 different EGFP-tagged wild-type (WT) Rab GAPs in Oli-neu cells using a plasmid ratio of 2:1 (EGFP-TBC/PLP-EGFP). Cells transfected with 
both PLP-EFP and YFP were used as a reference. 16 h after transfections, the cells were switched to serum-free medium, and the medium was collected after 
4 h of further incubation before submitting it to sequential centrifugation steps. The resulting 100,000 g pellets (exosome fraction) of each centrifugation 
step were analyzed by Western blotting for PLP-EGFP and the EGFP-TBCs (Rab GAPs) by anti-GFP antibodies. The mean of three independent experiments 
is shown in the graph. Those Rab GAPs that reduced exosome release of PLP below 60% of the control (boxed), were compared with their catalytically 
inactive arginine to alanine (RA) mutants, and the zoomed-in graph is shown in B. Error bars indicate the SD. (C) Western blot of the cell lysates (CL) and 
100,000 g pellets (P100) is shown for one representative experiment with TBC1D10.225 Rab35 in exosome biogenesis • Hsu et al.
GDP-locked Rab35
S22N were mainly found within the cytosol 
and in vesicles that contained PLP and Lamp-1, identifying 
them as late endosomes/lysosomes (Fig. 4, A and B). Similar 
findings were obtained when Rab35 and its mutant were ex-
pressed in HeLa cells, with the exception of more intracellular 
wild-type EGFP-Rab35 in vesicles containing PLP-myc (Fig. S2). 
We observed an expansion of the cell surface area after expres-
sion of either wild-type Rab35 or constitutively active GTP-
locked Rab35
Q67A (Fig. 4 A).
To obtain further evidence for the plasma membrane   
localization of Rab35, we analyzed the expression of Rab35 
in myelin, a plasma membrane extension of oligodendrocytes 
which is formed during the development of the central nervous 
system by the spiral wrapping of glial membrane around the 
axons (Sherman and Brophy, 2005; Simons and Trotter, 2007; 
Barres, 2008). Indeed, we detected Rab35 at relatively high 
levels  in  the  lysates  of  purified  myelin  by Western  blotting   
(Fig. 4 D). Purified myelin did not contain glial fibrillary acidic 
protein (GFAP) or synaptophysin proteins specific to astro-
cytes and neurons, confirming the purity of isolated myelin   
(Fig. 4 E). Although the majority of myelin consists of tightly 
stacked membrane bilayers with no space for MVBs, a frac-
tion of myelin is composed of more loosely organized mem-
brane that contains larger cytoplasmic channels (e.g., paranodal 
Rab35 (>2,000 pmol/h of hydrolyzed GTP; Fig. 2). We coex-
pressed the GTP-locked Rab35
Q67A mutant, which is resistant to 
GAP activity, with TBC1D10B and observed an approximate 
twofold increase in exosome release of PLP (Fig. 3, A and B).
Because our results from the Rab GAP screen pointed to a 
possible role of Rab35 in the exosome pathway, we used the 
dominant-negative mutant of Rab35 (Rab35
N120I) to interfere 
with its function and found that it significantly decreased re-
lease of PLP with exosomes (Fig. 3, C and F). We continued the 
analysis of the function of Rab35 by performing RNAi knock-
down experiments. Knockdown of Rab35 by two rounds of 
siRNA nucleofection efficiently depleted Rab35 from the cell 
lysate and resulted in a significant reduction of PLP recovery 
from the exosomal membrane fraction (Fig. 3, D–F), confirm-
ing the findings with the dominant-negative mutant. Relatively 
little is known about the function of Rab35 except of its role   
in receptor recycling, cytokinesis, and actin reorganization 
(Kouranti et al., 2006; Patino-Lopez et al., 2008; Sato et al., 
2008; Walseng et al., 2008; Zhang et al., 2009).
To  analyze  where  Rab35  may  act  in  oligodendroglial 
cells, we analyzed the localization of EGFP-tagged Rab35 
by confocal microscopy. Wild-type Rab35, the GTP-locked 
Rab35
Q67A, and its GAP, TBC1D10B, were detected at the plasma   
membrane, whereas the nucleotide-free Rab35
N120I and the 
Figure 2.  Identification of Rab35 as the target of TBC1D10A–C. Biochemical GAP assays were performed using recombinant hexahistidine-GST–tagged 
human Rab GTPases and hexahistidine-tagged TBC1D10 family proteins. Reactions were performed for 60 min at 37°C, using 100 pmol GST-Rab and   
10 pmol hexahistidine-tagged TBC1D10A, -B, or -C. GTP hydrolysis is plotted in picomoles per hour. Error bars represent SD.JCB • VOLUME 189 • NUMBER 2 • 2010   226
of the PLP-containing intracellular vesicles. Although vesicle 
size was unaffected, the total number of vesicles increased by 
35% after Rab35 knockdown (Fig. 5, A–C). These vesicles 
were identified as late endosomes/lysosomes based on their   
colocalization with Lamp-1. The intracellular accumulation 
of PLP in Lamp-1–positive vesicles and the reduction in exo-
some secretion after Rab35 depletion suggests that a pathway 
from the endosomal system to the plasma membrane is regu-
lated by Rab35.
To analyze the possibility that Rab35 controls vesicular   
movement, time-lapse experiments were performed using Lyso-
Tracker as a probe to identify PLP/Lamp-1–containing endo-
somes  (85.6  ±  2.7%  of  the  LysoTracker-labeled  vesicles 
contained PLP-EGFP; n = 1,522 vesicles analyzed). The effects 
of  the  constitutive  active  and  inactive  mutants  of  Rab35   
were compared in their ability to influence the mobility of   
endosomes. We used a recently developed algorithm to indentify 
and track individual vesicles automatically in a video sequence 
(Westphal et al., 2008). Data from 47 videos from three in-
dependent experiments were pooled to provide a quantitative   
assessment  of  vesicle  motility.  Surprisingly,  we  found  that   
active GTP-locked Rab35
Q67A slightly reduced the motility of 
LysoTracker-labeled vesicles (by 14.6% ± 3.8% as compared 
with  Rab35
S22N;  n  =  1,800  vesicles;  P  <  0.001,  Welch’s 
loops and abaxonal space; Salzer, 2003). We performed elec-
tron microscopy to analyze whether these structures contained 
MVBs. MVBs were frequently found in noncompacted regions 
of myelin (Fig. 4 F; Trapp et al., 1989), and immunoelectron 
microscopy revealed that MVBs contained PLP (Fig. 4 F).   
Because the Rab35 antibody did not work reliably in immuno-
histochemistry, we purified noncompacted myelin from crude 
myelin by sucrose gradient centrifugations to determine the lo-
calization of Rab35 in myelin. Rab35 was not found in the light   
fraction, which is enriched in compact myelin, but was recov-
ered from the heavier fraction, which also contained contactin, 
a protein which localizes to the paranodal junction (Fig. 4 E; 
Rios et al., 2000).
To define the steps at which Rab35 might act, we com-
pared the effects of the dominant-negative Rab7 and Rab35 
mutants. We found that only the expression of Rab7
T22N but   
not Rab35
N120I or Rab35
S22N resulted in an enlargement of PLP-
containing, Lamp-1–positive organelles and increased the co-
localization of PLP and Lamp-1 (Fig. 4, A and C; and Fig. S3). In 
addition, we only observed a reduction of EGF degradation after   
Rab7
T22N but not after Rab35
N120I expression (Fig. S3), suggest-
ing that lysosomal degradation is not regulated by Rab35.
To determine how Rab35 functions, we performed RNAi 
experiments to deplete Rab35 and analyzed the number and size 
Figure 3.  Inhibition of Rab35 function reduces exo-
some secretion of PLP. (A) Cells were transfected with 
PLP-myc, TBC1D10B, and either YFP or Rab35
Q67A. 
The amounts of PLP in the cell lysates (CL) and 100,000 g 
pellets (P100) were quantified, and the results of two 
experiments performed in duplicates are shown in B 
(values represent the mean ± SD; *, P < 0.05; Welch’s 
two-sample t test). (C) Cells were transfected with   
PLP-myc together with either wild-type (WT) Rab35 or the 
dominant-negative mutant (Rab35
N120I). (D and E) After   
delivery of control (Ctl) or siRNA against Rab35 into 
cells by nucleofection, the cell lysates were analyzed 
by Western blotting with Rab35 antibodies to moni-
tor knockdown efficiency. Actin and Rab5 were used 
as controls. The amount of PLP in the cell lysates and 
100,000  g  pellets  were  determined  after  Rab35 
RNAi. (F) Results are expressed as the mean ± SD of 
four experiments (*, P < 0.05; one-sample t test and 
Welch’s two-sample t test).227 Rab35 in exosome biogenesis • Hsu et al.
Figure 4.  Localization of Rab35. (A) Oli-neu cells were transfected with PLP-myc together with EGFP-Rab35
S22N, EGFP-Rab35
N120I, EGFP-Rab35
Q67A, or wild-type 
EGFP-Rab35 (WT) and analyzed by confocal microscopy. Wild-type and the GTP-locked Rab35
Q67A were detected at the plasma membrane, whereas the GDP-
locked Rab35
S22N and the nucleotide-empty EGFP-Rab35
N120I were mainly found within the cytosol and in vesicles that contained PLP and Lamp-1. (B) Oli-neu cells 
were cotransfected with EGFP-TBC1D10B and PLP-myc and analyzed by confocal microscopy. (C) Quantification of colocalization of PLP with Lamp-1 within 7 × 
7–µm intracellular regions after coexpression with the different protein Rab35 mutants is shown (n = 27–38). The values represent the mean ± SD. (D) Myelin 
(total) and myelin subfractions (light and heavy) were purified from the brain homogenates (brain) of adult mice, and the amounts of Rab35, PLP/DM20, and 
contactin were determined by Western blotting. Rab35 was detected in purified myelin (total) and in the subfraction of higher density (heavy). (E) Purified myelin 
did not contain relevant levels of GFAP or synaptophysin proteins, confirming the purity of isolated myelin. (F) Immunoelectron microscopy analysis of myelin in the 
spinal cord of adult mice with PLP antibodies. The left image shows an MVB within a cytoplasmic channel of compact myelin, and the right image shows an MVB 
in the abaxonal space. MVBs (boxed areas) are displayed at higher magnification in the insets. Bars: (A and B) 10 µm; (F) 200 nm.JCB • VOLUME 189 • NUMBER 2 • 2010   228
Figure 5.  Rab35 functions in recruitment of the endosomal vesicle to the plasma membrane. (A) Control (Ctl) or siRNA against Rab35 was delivered into 
cells by nucleofection, and the cells were imaged by immunofluorescence microscopy to detect PLP-myc. (B and C) Vesicle number and size are displayed 
in a histogram. Note that vesicle size was unaffected, whereas the number of vesicles increased after Rab35 knockdown (n = 80 cells from three inde-
pendent experiments). (D) To analyze vesicular movement, PLP-myc was cotransfected with wild-type or mutant EGFP-tagged Rab35, cells were stained 
with LysoTracker red DND-99, and time-lapse images were acquired at 1 frame every 2 s at 37°C. The motility of LysoTracker-labeled vesicles was slightly 
reduced when active GTP-locked Rab35
Q67A was expressed (n = 1,800 vesicles from three independent experiments). (E and F) The mean number of 
LysoTracker green DND-26–labeled vesicles in a field of 12.7 µm × 12.7 µm (unit area) was determined in the evanescent excitation field. Expression of 
the GTP-locked Rab35
Q67A increased the number of vesicles in the TIRF evanescence field as compared with the GDP-locked Rab35
S22N (n = 70 cells from 
three independent experiments; mean ± SD; ***, P < 0.001; Welch’s two-sample t test). (G) The mobility of LysoTracker green DND-26–labeled vesicles 229 Rab35 in exosome biogenesis • Hsu et al.
In summary, we provide new evidence that Rab35 and its 
GAPs TBC1D10A–C regulate exosome release of PLP in oligo-
dendroglial cells, possibly by controlling the docking/tethering 
of endocytic vesicles with the plasma membrane. The functional 
involvement of Rab35 in an endocytic recycling pathway is 
consistent with previous studies demonstrating a role for Rab35 
in the recycling of transferrin and yolk receptors in HeLa cells 
and Caenorhabditis elegans, respectively (Kouranti et al., 2006; 
Sato et al., 2008). Although a previous study indicates that Rab35 
controls a fast recycling pathway from peripheral endocytic 
compartments to the plasma membrane (Sato et al., 2008), our 
work implies that Rab35 also acts on late endosomes/MVBs. 
Rab11, a well-known regulator of endosomal recycling, has also 
been linked to the control of exosome release in K562a cells 
(Savina et al., 2005). Interestingly, work in C. elegans showed 
that the combined knockdown of Rab35 and -11 leads to a dra-
matic enhancement of intracellular accumulation of endosomal 
cargo (Sato et al., 2008). Thus, it is plausible that Rab35 and -11 
play a dual role in endocytic recycling rather than acting in   
sequential stages. Further work will be required to define the 
precise functional contributions of Rab35 and -11 in exosome 
biogenesis. It will also be important to find out whether the   
machinery involved in exosome secretion is related to the one 
required for the biogenesis of secretory lysosomes or melano-
somes (Stinchcombe and Griffiths, 2007; Idone et al., 2008; 
Delevoye et al., 2009). Interestingly, a recent study shows that 
Rab27 not only functions in melanosome biogenesis but also   
in the exosome secretion pathway (Ostrowski et al., 2010).   
Together with this study, these findings provide a molecular   
basis for understanding MVB trafficking and exosome biogene-
sis. This is important as these vesicles have been implicated   
in various different cellular functions (e.g., intercellular signal-
ing and transfer of mRNA) and disease states (e.g., prion dis-
ease and tumor spreading). Thus, strategies to interfere with 
their biogenesis such as blocking Rab35 function will be impor-
tant to get a better understanding of their physiological and 
pathological relevance. The function of glial-derived exosomes 
is also unclear. The finding that MVBs are not only found   
in the soma and the processes of oligodendrocytes but also   
within the periaxonal space of myelin points to the interesting 
possibility that they transfer cargo into the axon. The iden-
tification and characterization of Rab35 effectors is likely to 
yield new insights into how exosomes are generated and where 
the release occurs.
Materials and methods
Antibodies, plasmids, and other reagents
The following primary antibodies were used: rat anti–Lamp-1 (CD107a; 
BD), rabbit anti-myc (Millipore), mouse anti-HA (16B12; Covance), mouse 
anti-PLP (3F4; a gift from K.-A. Nave, Max Planck Institute for Experimental 
two-sample t test; Fig. 5 D). One possible explanation is that 
Rab35
Q67A promotes vesicle docking/tethering. To test this pos-
sibility, cells were imaged with total internal reflection fluores-
cence (TIRF) microscopy to observe the vesicles just beneath 
the plasma membrane. Indeed, we found that that Rab35
Q67A  
increased the number of LysoTracker-labeled vesicles within 
the evanescent excitation field (120 nm) by around 50% as 
compared with GDP-locked Rab35
S22N (Fig. 5, E and F). To 
determine whether these vesicles were docked/tethered to the 
plasma membrane, we performed time-lapse TIRF experiments. 
To estimate vesicle motility, the temporal colocalization was   
determined by calculating the Pearson’s correlation coeffi-
cient of pairs of images separated by time (Huang et al., 2007).   
In such an analysis, the degree of temporal colocalization is   
inversely related to vesicle motility. Expression of Rab35
Q67A 
increased vesicle immobilization as compared with the inactive 
form of Rab35 (Fig. 5 G).
Because exosome release is known to be stimulated by 
intracellular Ca
2+ levels (Savina et al., 2003; Krämer-Albers 
et al., 2007), we determined vesicular fusion after Ca
2+ stimulation 
by whole-cell capacitance measurements (Cm; Voets, 2000). Cells 
were held in whole-cell patch-clamp configuration and dialyzed 
through the pipette with the Ca
2+-caged nitrophenyl (NP)-EGTA 
and a mixture of two Ca
2+-sensitive fluorescent dyes, Fura-4 
and -2FF, which allows us to precisely measure [Ca
2+]i over 
a large concentration range (Voets, 2000). 2–3 min after the 
whole-cell configuration, a strong UV flash was applied to the 
cells, causing the photolysis of NP-EGTA and leading to a step-
like homogenous increase of [Ca
2+]i. After flash photolysis, the 
change in Cm consisted of a fast initial phase, the exocytic burst, 
followed by a slower sustained phase of secretion, which is 
similar but slower to what has been reported in other cell types 
(Fig. 5 H; Voets, 2000). The exocytic burst component repre-
sents the readily releasable pool (RRP), whereas the sustained 
component represents the recruitment of fusion component ves-
icles from a reserve pool. In cells overexpressing a dominant-
negative mutant of Rab35 (Rab35
S22N), the mean RRP size in 
mutant cells was markedly smaller than that of wild-type 
Rab35-expressing cells (Rab35: 1.12 ± 0.12 pF, n = 15; Rab35
S22N: 
0.48 ± 0.10 pF, n = 11; P < 0.001; Fig. 5 I). Interestingly, al-
though the release kinetics of RRP (during 0–1 s) was identical, 
the size of RRP of was reduced in Rab35
S22N as compared with 
wild-type Rab35-expressing cells (Rab35: 76.9 ± 13.1 ms,   
n = 10; Rab35
S22N: 73.4 ± 21.8 ms, n = 5; P > 0.05; Fig. 5 I). In 
addition,  the  time  constant  of  the  slow  component  increased   
significantly  after  expression  of  Rab35
S22N  (Rab35:  535.9  ±   
81.2 ms, n = 10; Rab35
S22N: 1,300.4 ± 344.1 ms, n = 5; P < 0.05). 
Although these data do not distinguish the vesicle population 
undergoing fusion, they do show a role of Rab35 in a Ca
2+-
regulated pathway of vesicle fusion with the plasma membrane.
was determined by time-lapse TIRF microscopy and analyzed by calculating the temporal correlation coefficient between pairs of images separated by 
time. The degree of temporal colocalization is inversely related to vesicle motility (n = 35 videos from three independent experiments; mean ± SEM).   
(H) Representative traces of intracellular Ca
2+ concentration (top) and membrane capacitance (bottom) in response to flash photolysis of caged Ca
2+  
(indicated by arrows) in cells expressing wild-type (black trace) and GDP-locked Rab35
S22N (gray trace). Error bars represent SEM. (I) A decrease in 
capacitance during the exocytotic burst (0–1 s) and an increase in time constant of the slow compartment were observed in cells expressing Rab35
S22N  
(*, P < 0.05; ***, P < 0.001; Mann-Whitney test; mean ± SEM). Bars: (A) 10 µm; (E) 5 µm.
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Medicine, Göttingen, Germany), mouse anticontactin (K67/25; Neuro-
Mab), rabbit anti-Rab35 (a gift from A. Echard, Institut Curie, Paris, 
France), rabbit anti-GFAP (Promega), mouse antisynaptophysin (Synaptic 
Systems), rabbit anti-GFP (Abcam; Invitrogen), mouse anti-myc (Cell Signal-
ing Technology), and mouse antiactin (AC-40; Sigma-Aldrich). Secondary 
antibodies were purchased from Dianova. The following expression plas-
mids were used: EGFP–Rab GAPs and their catalytically inactive mutants 
(Haas et al., 2005), EGFP–Rab GTPases and their mutants (Yoshimura   
et al., 2007), GFP-Rab7 and -Rab7
T22N (provided by M. Zerial, Max Planck 
Institute  of  Molecular  Cell  Biology  and  Genetics,  Dresden,  Germany), 
pEYFP-C1 (BD), and PLP-myc and -EGFP (Trajkovic et al., 2008). Colloidal 
gold conjugates to protein A were obtained from the Cell Microscopy   
Center, University Medical Center Utrecht, Utrecht, Netherlands.
To produce DsRed2-Rab35 and its constitutively active and inactive 
mutations, Rab35 sequences were amplified from pEGFP-Rab35 plasmids 
with  PCR  (primers,  5-TTAAGCTTCGATGGCCCGGGACTACGACC-3 
and 5-TTGGATCCTTAGCAGCAGCGTTTCTTTCGTTTACTG-3), restriction 
digested, and inserted into the pDsRed2-C1 plasmid (Invitrogen) between 
the HindIII and BamHI restriction sites.
MS
Exosomes purified from Oli-neu cell lines were separated by a 4–12%   
Bis-Tris gradient NuPAGE gel (Invitrogen) and stained with Colloidal blue 
(Invitrogen). Each gel lane was cut into 25 slices, and proteins were in-gel 
digested with trypsin. Tryptic peptides were analyzed on an LTQ XL   
Orbitrap (Thermo Fisher Scientific) coupled to an LC system (1100 series; 
Agilent Technologies). Peptides were separated at a flow rate of 200 nl/min 
on a reversed phase column (C18; Reprosil). Elution of the peptides was 
performed with a 50-min gradient from 7–40% mobile phase B (80% aceto-
nitrile  and  0.15%  formic  acid).  Peak  lists  were  searched  against  the   
National  Center  for  Biotechnology  Information  nonredundant  database   
using Mascot version 2.2 (Matrix Science, Inc.) as a search engine. Mass 
accuracy was 5 ppm for both parent ion and fragment ions. The peptides 
were constrained to be tryptic with a maximum of two missed cleavages. 
Carbamidomethylation of cysteines was considered a fixed modification, 
whereas oxidation of methionine residues was considered a variable modi-
fication. The proteins found in our exosome preparation were compared 
with proteins identified previously in exosomes from other cell types (Barile 
et al., 2005; Segura et al., 2005; Aoki et al., 2007; Valadi et al., 2007; 
Conde-Vancells et al., 2008).
Cell culture, transfection, and RNAi
The oligodendroglial precursor cell line Oli-neu (provided by J. Trotter,   
University  of  Mainz,  Mainz,  Germany)  was  cultured  as  previously  de-
scribed (Trajkovic et al., 2006). The cells were seeded on poly-l-lysine– 
precoated plastic Petri dishes or glass coverslips and cultured at 37°C with 
5% CO2 in SATO medium supplied with 5% horse serum. Transient trans-
fections were performed using TransIT-LT1 transfection reagent (Mirus)   
according  to  the  manufacturer’s  instructions.  siRNA  was  delivered  into   
Oli-neu cells by electrophoresis with a Basic Neuron Nucleofector kit 
(Lonza) in a two-step fashion as previously described (Trajkovic et al., 
2006).  For  RNAi,  we  used  the  pooled  oligonucleotides  targeting  four   
sequences of mouse Rab35 (L-042604-01) and the pooled nontargeting 
oligonucleotides (D-001810-10) as control from Thermo Fisher Scientific.
Exosome purification
Exosomes were prepared as described previously (Trajkovic et al., 2008). 
Before the preparation, the culture medium was replaced by serum-free 
medium, and media were then collected and centrifuged for 10 min at 
3,000 g and two times for 10 min at 4,000 g before subjecting it for ultra-
centrifugation at 10,000 g for 30 min and at 100,000 g for 1 h. The pel-
lets were resuspended in sample buffer (20% glycerol, 4 mM EDTA, 
4% SDS, 4% 2-mercaptoethanol, and 100 mM Tris-HCl, pH 6.8). Cell ly-
sates were incubated for 10 min on ice with lysis buffer (2% Nonidet P-40, 
0.2% SDS, and 1 mM EGTA in PBS supplied with Complete protease in-
hibitor cocktail from Roche), scraped, and centrifuged at 10,000 g for 10 min. 
A fraction of the supernatant was mixed with sample buffer before subject-
ing it to 10 or 12% SDS-PAGE and transfer to nitrocellulose membranes. 
Western blots were revealed by enhanced chemiluminescence (Thermo 
Fisher Scientific), and bands were quantified using ImageJ software (National 
Institutes of Health).
Rab GAP assays
Rab  GAP  assays  using  recombinant  hexahistidine-GST–tagged  human   
Rab GTPases and hexahistidine-tagged TBC1D10 family proteins were   
performed as described previously (Haas et al., 2005; Fuchs et al., 2007; 
Yoshimura et al., 2007). All proteins tested corresponded to the full-length 
open reading frames. In brief, standard assays were performed for 60 min 
at 37°C, using 100 pmol -[
32P]GTP preloaded GST-Rab and 10 pmol 
hexahistidine-tagged TBC1D10A, -B, or -C. Released inorganic phosphate 
was taken as a measure of GTP hydrolysis in picomoles per hour.
In our initial experiments of Rab GAPs, we observed some activity 
of more than one GAP toward Rab35; however, unlike TBC1D10A–C 
none of these was specific for Rab35. This was because of a C-terminal 
cleavage that occurs during preparation of the recombinant Rab35 pro-
tein. An altered preparation method using low temperature expression for 
shorter time yields predominantly full-length Rab35. This altered method was 
used in Yoshimura et al. (2007) and resolved the problems we had ob-
served relating to nonspecific activation of Rab35.
Immunofluorescence, microscopy, and image analysis
Immunofluorescence  was  performed  as  described  previously  (Trajkovic   
et al., 2006). Before the primary and fluorescent secondary antibody label-
ing, the cells were fixed with 4% paraformaldehyde in PBS, washed, and 
permeabilized with 0.1% Triton X-100 for 1 min. Fluorescence images were 
acquired with a wide-field fluorescence microscope (DMRXA; Leica) through 
a 40× HCX Plan-Fluotar objective (Leica) or a confocal microscope setup 
and its software (LSM 510 [Carl Zeiss, Inc.]; or TCS SP2 AOBS [Leica]) with 
a 63× NA 1.4 oil Plan-Apochromat objective (Carl Zeiss, Inc.).
TIRF microscopy was performed with a prism-based setup. The   
images were acquired with a camera (Cascade 512B; Photometrics) on a 
microscope (Axiovert 135; Carl Zeiss, Inc.) with a 63× water-immersed 
objective (Leica; pixel size, 0.25 × 0.25 µm). The excitation light was 
generated with an argon laser (488 nm), and the fluorescence emission 
signals were filtered with an HQ 515/30 band-pass filter. Wide-field   
fluorescence images were obtained with the same capturing settings as   
the TIRF images, using a 450–490 band-passed excitation light generated 
with a monochromator.
To  analyze  vesicular  movement,  PLP-myc  was  cotransfected  with 
wild-type  or  mutant  EGFP-tagged  Rab35,  and  cells  were  stained  with   
50 nM LysoTracker red DND-99 (Invitrogen) for 10 min 24–30 h after 
transfection and washed with imaging medium (160 mM NaCl, 4.5 mM Kcl, 
2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM Hepes, pH 7.4), 
and the time-lapse images were acquired with a TCS SP2 AOBS confocal 
microscope at 1 frame every 2 s at 37°C. The pinhole was set at 300 µm, 
and a pixel size of 0.12 µm × 0.12 µm was used.
The  velocities  of  the  vesicles  were  automatically  analyzed  using   
a  previously  described  algorithm  with  MATLAB  (The  MathWorks,  Inc.; 
Westphal et al., 2008). The images were smoothened by convolution with 
a Gaussian function of 2 pixels full width at half maximum, and vesicles 
were found as the local maxima, which exceed a threshold of 20% relative 
to the brightest object. Vesicles were tracked by minimizing the sum of the 
squared distances moved of all particles. The maximally allowed speed of 
a particle was 8 pixels/frame.
For PLP/Lamp-1 colocalization assay, an 8-bit confocal image with 
a resolution of 0.071 µm/pixel of a 7-µm × 7-µm intracellular region was 
obtained; signals of PLP-myc and Lamp-1 channels of the image were sub-
jected to a calculation using a self-written ImageJ plugin for Pearson’s cor-
relation coefficient. To calculate vesicle size and number, confocal images 
with the aforementioned pixel size of a 73-µm × 73-µm field were taken 
and analyzed with ImageJ. For the correlation change in image series   
acquired with the TIRF microscope, an image region of 15.2 µm × 15.2 µm 
containing cells expressing DsRed2-Rab35, identified in the wide-field 
fluorescence channel, was cropped, and Pearson’s correlation coefficient 
was calculated between pairs of images separated by time (first frame and 
the following frames within the video sequence).
Capacitance and Ca
2+ measurements
Experimental  procedures  for  whole-cell  patch-clamp  and  capacitance 
measurements were performed essentially as described previously (Voets, 
2000). Mounted cells were patched with 3–4 MΩ pipettes while perfused 
with extracellular solution. The Lindau-Neher technique was used for the 
capacitance measurements, and the data were acquired with the high 
time resolution PULSE software (HEKA). In the flash experiments, cells were 
cotransfected with PLP-myc and wild-type or mutant EGFP-tagged Rab35 
for 16–20 h. Exocytosis was elicited by photorelease of caged Ca
2+  
(NP-EGTA), which was preloaded into the cell via the patch pipette. Flashes 
of UV light were generated by a flash lamp (Dr. Rapp Optoelektronik) and 
coupled to an inverted microscope (Axiovert 200; Carl Zeiss, Inc.). Fluores-
cence excitation light was generated by a monochromator (Polychrome II;   231 Rab35 in exosome biogenesis • Hsu et al.
degradation  by  dominant-negative  Rab7  but  not  Rab35.  Table  S1,  in-
cluded as an Excel file, shows the MS analysis of Oli-neu–derived exo-
somes.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.200911018/DC1.
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as described previously (Voets, 2000) using a 1:1 mixture of the Ca
2+- 
sensitive dyes Fura-4F (Kd = 1 µM) and Furaptra (Kd = 40 µM). The signal 
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Myelin preparation
The myelin preparation was performed essentially as described previously 
(Larocca and Norton, 2007). In brief, the brains from 3–6-mo-old mice 
were homogenized in PBS containing protease inhibitors by sonication. 
The brain homogenate was put on top of two-step sucrose gradients (0.32 
and 0.85 M sucrose in preparation buffer containing 5 mM EDTA and 10 mM 
Hepes, pH 7.4). After the gradients were centrifuged at 75,000 g for   
30 min, the interfaces were collected, diluted at least 10 times with H2O, 
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H2O and recovered by 10-min centrifugations at 12,000 g (crude myelin), 
and the protocol was repeated to obtain purified myelin.
To separate the heavy and light myelin (Rios et al., 2000), the crude 
myelin pellet was resuspended with preparation buffer, put on top of a 
three-step sucrose gradient (0.32, 0.62, and 0.8 M sucrose in preparation 
buffer), and centrifuged at 75,000 g for 30 min. The light and heavy   
myelin fractions were collected at the 0.32/0.62 M and 0.62/0.8 M   
sucrose interfaces, respectively. The fractions were washed with H2O and 
recovered by centrifugations for 20 min at 75,000 g and twice for 10 min 
at 12,000 g. The protein concentrations of the brain homogenate and   
myelin preparations were determined by the Bradford assay.
EGF degradation
The EGF degradation assay was performed as described previously   
(Trajkovic et al., 2008). Cells transfected with EGFP-tagged EGF receptor 
(EGFR-EGFP) were incubated with 50 ng/ml Alexa Fluor 555–labeled EGF 
(Invitrogen) for 15 min, washed, and incubated for 4 h in conditioned   
culture medium to allow EGF degradation. For quantification, images of 
randomly selected transfected cells were recorded at fixed settings below 
pixel-value saturation, and fluorescence intensities were quantified using 
Meta Imaging Series 6.1 software (MDS Analytical Technologies).
Immunoelectron microscopy
Immunoelectron  microscopy  was  performed  as  described  previously   
(Werner et al., 2007). Mice were fixed by transcardial perfusion with 
4% formaldehyde and 0.2% glutaraldehyde in 0.1 M phosphate buffer con-
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cellulose and 2.3 M sucrose. For immunolabeling, sections were incubated 
with antibodies specific for PLP, which was detected with protein A–gold 
(10 nm). Sections were analyzed with a LEO EM912 Omega (Carl Zeiss, 
Inc.), and digital micrographs were obtained with an on-axis 2,048 × 
2,048–pixel charge-coupled device camera (Proscan).
Statistical analysis
The significance of data was evaluated with the statistical program R using 
Welch’s two-sample t test or one-sample t test.
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